Regional cerebral metabolic asymmetries replicated in an independent group of patients with panic disorder

Biological Psychiatry

Volumn 44, Issue 10, 1998, Pages 998-1006

  Nordahl, Thomas E ^a,b,c   Stein, Murray B ^d   Benkelfat, Chawki ^e   Semple, William E ^f   Andreason, Paul ^g   Zametkin, Allen ^h   Uhde, Thomas W ⁱ   Cohen, Robert M ^h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Napa State Hospital   (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MCGILL UNIVERSITY   (Canada)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

^g CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^h NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

ⁱ WAYNE STATE UNIVERSITY   (United States)

Author keywords

Hemispheric asymmetries; Panic disorder; Regional cerebral glucose metabolism

Indexed keywords

CLOMIPRAMINE; FLUORODEOXYGLUCOSE F 18; IMIPRAMINE;

ADULT; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; COMPULSION; CONTROLLED STUDY; FEMALE; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HEMISPHERE; HIPPOCAMPUS; HUMAN; MALE; MENTAL DISEASE; OBSESSION; PANIC; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BRAIN CHEMISTRY; FEMALE; FUNCTIONAL LATERALITY; GLUCOSE; HIPPOCAMPUS; HUMANS; IMIPRAMINE; MALE; PANIC DISORDER; PREFRONTAL CORTEX; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032533638     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00026-2     Document Type: Article

References (31)

1. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed rev. 1987;American Psychiatric Press, Washington, DC.
2. Baxter L.R., Phelps M.E., Mazziotta J.C., Guze B.H., Schwartz J.M., Selin C.E. Local cerebral glucose metabolic rates in obsessive-compulsive disorder A comparison with rates in unipolar depression and in normal controls . Arch Gen Psychiatry. 44:1987;211-218.
3. Baxter L.R., Schwartz J.M., Phelps M.E., et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry. 46:1989;243-250.
4. Benkelfat C., Nordahl T.E., Semple W.E., King A.C., Murphy D.L., Cohen R.M. Local cerebral glucose metabolic rates in obsessive-compulsive disorder patients treated with clomipramine. Arch Gen Psychiatry. 47:1990;840-848.
5. Brooks RA (1982): Alternative formula for glucose utilization using labeled deoxyglucose. J Nucl Med 23:538-539. mine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons. Acta Physiol Scand 67:481.
6. Brooks RA (1982): Alternative formula for glucose utilization using labeled deoxyglucose. J Nucl Med 23:538-539. mine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons. Acta Physiol Scand 67:481.
7. Clark C., Carson R., Kessler R., et al. Alternative statistical models for the examination of clinical positron emission tomography/fluorodeoxyglucose data. J Cereb Blood Flow Metab. 5:1985;142-150.
8. Cohen R.M., Semple W.E., Gross M., Holcomb H.H., Dowling M.S., Nordahl T.E. Functional localization of sustained attention Comparison to sensory stimulation in the absence of instruction . Neuropsychiatry Neuropsychol Behav Neurol. 1:1988;3-20.
9. Cohen R.M., Semple W.E., Gross M., King A.C., Nordahl T.E. The metabolic pattern of sustained auditory discrimination. Exp Brain Res. 92:1992;165-172.
10. De Cristofaro M.T.R., Sessarego A., Pupi A., Biondi F., Faravelli C. Brain perfusion abnormalities in drug-naive, lactate-sensitive panic patients A SPECT study . Biol Psychiatry. 33:1993;505.
11. Fyer AJ, Endicott J, Manuzza S, Klein DF (1985): Schedule for Affective Disorders and Schizophrenia - Lifetime Version [modified for the study of anxiety disorders]. New York: Anxiety Disorders Clinic, New York State Psychiatric Institute.
12. Goddard A.W., Charney D.S. Toward an integrated neurobiology of panic disorder. J Clin Psychiatry. 58:(suppl 2):1997;4-11.
13. Gur R.C., Gur R.E., Resnick S.M., Skolnick B.E., Alavi A., Reivich •. The effect of anxiety on cortical cerebral blood flow and metabolism. J Cereb Blood Flow Metab. 7:1987;173-177.
14. Kuikka J.T., Pitkanen A., Leopola U., et al. Abnormal regional benzodiazepine receptor uptake in the prefrontal cortex in patients with panic disorder. Nucl Med Comm. 16:1995;273-280.
15. Lauterback E.C., Jackson J.G., Wilson A.N., Dever G.E.A., Kiersh A.D. Major depression after left posterior globus pallidus lesions. Neuropsychiatry Neuropsychol Behav Neurol. 10:1997;9-16.
16. Martinot J.L., Hardy P., Feline A., et al. Left prefrontal glucose hypometabolism in the depressed state A confirmation . Am J Psychiatry. 147:1990;1313-1317.
17. Matochik J.A., Nordahl T.E., Gross M., et al. Effects of acute stimulant medication on cerebral metabolism in adults with hyperactivity. Neuropsychopharmacology. 8:1993;377-386.
18. Metter E.J., Riege W.H., Kuhl D.E., Phelps M.E. Cerebral metabolic relationships for selected brain regions in healthy adults. J Cereb Blood Flow Metab. 4:1984;1-7.
19. Nordahl T.E., Benkelfat C., Semple W.E., Gross M., King A.C., Cohen R.M. Cerebral glucose metabolic rates in obsessive compulsive disorder. Neuropsychopharmacology. 2:1989;23-28.
20. Nordahl TE, Benkelfat C, Semple W, Gross M, Uhde TW, Cohen RM (1989): Metabolic rates in OCD and panic disorder. Presented at annual meeting of the APA, San Francisco.
21. Nordahl T.E., Semple W.E., Gross M., et al. Cerebral glucose metabolic differences in patients with panic disorder. Neuropsychopharmacology. 3:1990;261-272.
22. Phelps M.E., Huang S.C., Hoffman E.J., Selin C., Sokoloff L., Kuhl D.E. Tomographic measurement of local cerebral glucose metabolic rate in humans with [F-18]1-fluoro-2-deoxy-D-glucose Validation of method . Ann Neurol. 6:1979;371-388.
23. Reiman E.M., Raichle M.E., Butler F.K., Herscovitch P., Robins E. A focal brain abnormality in panic disorder, a severe form of anxiety. Nature. 310:1984;683-685.
24. Reiman E.M., Raichle M.E., Robins E., et al. The application of positron emission tomography to the study of panic disorder. Am J Psychiatry. 143:1986;469-477.
25. Robinson R.G., Kubos K.L., Starr L.B., Rao K., Price T.R. Mood disorders in stroke patients Importance of location of lesion . Brain. 107:1984;81-93.
26. Sheehan D.V. The Anxiety Disease. revised paperback edition :1986;Bantam Books, New York.
27. Sokoloff L., Reivich M., Kennedy C., Des Rosiers M.H., Patlak C.S., Pettigrew K.D., et al. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization Theory, procedure, and normal values in the conscious and anesthetized albino rat . J Neurochem. 28:1977;897-916.
28. Spielberger C.D., Gorsuch R.L., Lushene R.E. Manual for the State-Trait Anxiety Inventory. 1970;Consulting Psychologists Press, Palo Alto, CA.
29. Stewart R.S., Devous M.D., Rush A.J., Lane L., Bonte F.J. Cerebral blood flow changes during sodium-lactate-induced panic attacks. Am J Psychiatry. 145:1988;442-449.
30. Woods S.W., Koster K., Krystal J.K., et al. Yohimbine alters regional cerebral blood flow in panic disorder. Lancet. ii:1988;678.
31. Wu J.C., Buchsbaum M.S., Hershey T.G., Hazlett E., Sicotte N., Johnson J.C. PET in generalized anxiety disorder. Biol Psychiatry. 29:1991;1181-1199.